retatrutide clinical trial news of next-gen weight-loss drug brings it one step closer to FDA approval Retatrutide Phase 3 Results: TRIUMPH-1

Chicken Ratatouille A French-inspired meal made with the freshest local produce

The main differences between the two peptides are the following: Development and Approval: Semaglutide was developed later (2010) than liraglutide, and it also received FDA approval much more recently for type 2 diabetes treatment (2017), cardiovascular risk reduction in diabetes (2021) and overweight and obesity management in adults (2021) and adolescents (2023)

10.1016/j.ecoenv.2021.112851 109 LiL.LiuX.LiS.WangQ.WangH.XuM.et al (2021c)

Brand-Name Wegovy: Why Price Transparency Matters Brand-name Wegovy costs $1,349 per month at retail pricing, reflecting pharmaceutical company marketing, distribution, and development costs

Key Takeaways: Cognitive and Behavioral Benefits: GLP-1 drugs were linked to reduced risks of addiction, neurocognitive disorders like Alzheimers and dementia, and psychiatric conditions such as suicidal ideation and psychosis